Insight into intraindividual variability across neuropsychological tests and its association with cognitive dysfunction in patients with lupus.

autoimmune diseases health care outcome assessment psychology quality of life systemic lupus erythematosus

Journal

Lupus science & medicine
ISSN: 2053-8790
Titre abrégé: Lupus Sci Med
Pays: England
ID NLM: 101633705

Informations de publication

Date de publication:
10 2021
Historique:
received: 19 04 2021
accepted: 03 09 2021
entrez: 6 10 2021
pubmed: 7 10 2021
medline: 3 11 2021
Statut: ppublish

Résumé

Dispersion, or variability in an individual's performance across multiple tasks at a single assessment visit, has been associated with cognitive dysfunction (CD) in many neurodegenerative and neurodevelopmental disorders. We aimed to compute a dispersion score using neuropsychological battery (NB) tests and determine its association with CD in patients with SLE. CD was defined as a z-score of ≤-1.5 on ≥2 domains of the NB. To compute a type of dispersion score known as the intraindividual SD (ISD), the SD of age-adjusted and sex-adjusted z-scores was calculated for each visit in each patient. To estimate the association between ISD and cognitive status (CD and non-CD), we used multilevel logistic regression, adjusting for clinically important covariates. A total of 301 adult patients with SLE completed the NB at baseline, 187 of whom were reassessed at 6 months and 189 at 12 months. CD was observed in 35.2% of patients at baseline, 27.8% at 6 months and 28.0% at 12 months. Prior to covariate adjustment, the mean ISD for non-CD was 1.10±0.31 compared with 1.50±0.70 for CD. After adjusting for ethnicity, education, employment, socioeconomic status and anxiety/depression, there was a statistically significant association between ISD and CD (OR for one-unit increase in ISD: 13.56, 95% CI 4.80 to 38.31; OR for 1/10th-unit increase in ISD: 1.30, 95% CI 1.17 to 1.44). Findings were valid across multiple sensitivity analyses. This is the first study to show that patients with SLE who were classified as having CD by the NB had more variability across the NB tests (ie, higher ISD score) compared with those who were not classified as having CD.

Identifiants

pubmed: 34610995
pii: 8/1/e000511
doi: 10.1136/lupus-2021-000511
pmc: PMC8493902
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Semin Arthritis Rheum. 2018 Oct;48(2):240-255
pubmed: 29571540
Clin Neuropsychol. 1999 Aug;13(3):348-58
pubmed: 10726605
Clin Neuropsychol. 2012;26(4):654-74
pubmed: 22533778
Rheumatology (Oxford). 2020 Nov 1;59(11):3211-3220
pubmed: 32221602
Arthritis Rheum. 2009 May 15;61(5):680-7
pubmed: 19405004
Neuropsychologia. 2018 Oct;119:340-348
pubmed: 30176300
J Gerontol B Psychol Sci Soc Sci. 2002 Mar;57(2):P101-15
pubmed: 11867658
Neuropsychology. 2013 Jul;27(4):481-490
pubmed: 23876120
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Arthritis Care Res (Hoboken). 2020 Dec;72(12):1809-1819
pubmed: 31628718
J Intell. 2018 Mar 01;6(1):
pubmed: 31162439
Neuropsychology. 2019 Jul;33(5):599-608
pubmed: 30896235
Brain Lang. 1992 Apr;42(3):248-69
pubmed: 1606486
Psychol Aging. 1997 Sep;12(3):410-32
pubmed: 9308090
Ann Rheum Dis. 2010 Dec;69(12):2074-82
pubmed: 20724309
Arch Clin Neuropsychol. 2013 Nov;28(7):640-8
pubmed: 23832096
Arthritis Rheum. 1999 Apr;42(4):599-608
pubmed: 10211873
Semin Arthritis Rheum. 2019 Oct;49(2):260-266
pubmed: 30940467
Arthritis Care Res (Hoboken). 2013 Mar;65(3):372-81
pubmed: 22933364
Lupus. 2007;16(6):418-25
pubmed: 17664232
Nat Rev Dis Primers. 2016 Jun 16;2:16039
pubmed: 27306639
Arthritis Care Res (Hoboken). 2021 Sep;73(9):1243-1249
pubmed: 32433815
Res Dev Disabil. 2013 Feb;34(2):817-30
pubmed: 23220737
Neuropsychology. 2000 Oct;14(4):588-98
pubmed: 11055261
Arthritis Rheum. 2008 Nov;58(11):3286-98
pubmed: 18975345
Rheumatology (Oxford). 2018 Aug 1;57(8):1370-1376
pubmed: 29688532
JAMA. 2008 Aug 20;300(7):823-30
pubmed: 18714062
J Rheumatol. 2002 Feb;29(2):288-91
pubmed: 11838846
Arch Clin Neuropsychol. 2004 Mar;19(2):203-14
pubmed: 15010086
J Int Neuropsychol Soc. 2018 Jul;24(6):629-639
pubmed: 29553037
Arthritis Rheum. 2004 Oct 15;51(5):810-8
pubmed: 15478145

Auteurs

Jennifer Wei He (JW)

Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada.

Juan Pablo Diaz Martinez (JP)

Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Kathleen Bingham (K)

Psychiatry Department, Centre for Mental Health, University Health Network, Toronto, Ontario, Canada.

Jiandong Su (J)

Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Mahta Kakvan (M)

Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Maria Carmela Tartaglia (MC)

Krembil Neurosciences Centre, University of Toronto, Toronto, Ontario, Canada.

Lesley Ruttan (L)

Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada.

Dorcas Beaton (D)

Institute for Work and Health, University of Toronto, Toronto, Ontario, Canada.

Joan Wither (J)

Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
Krembil Neurosciences Centre, University of Toronto, Toronto, Ontario, Canada.

May Y Choi (MY)

Department of Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.

Marvin J Fritzler (MJ)

Department of Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.

Nicole Anderson (N)

Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Dennisse Bonilla (D)

Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Robin Green (R)

Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada.

Patricia Katz (P)

Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Zahi Touma (Z)

Institute for Work and Health, University of Toronto, Toronto, Ontario, Canada Zahi.Touma@uhn.ca.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Division of Rheumatology, University Health Network, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH